ARTICLE | Company News
AC Immune, Essex partner to develop undisclosed neurology candidate
June 9, 2017 3:13 AM UTC
AC Immune S.A. (NASDAQ:ACIU) partnered with Essex Bio-Technology Ltd. (HKSE:1061) to develop an undisclosed biologic. The companies said the candidate acts "on a unique neuroprotective mechanism" and will be developed to treat Alzheimer's disease (AD) and frontotemporal dementia. ...